- With Mayo Clinic cardiologist
Thomas Behrenbeck, M.D.
read biographyclose windowBiography of
Thomas Behrenbeck, M.D.
Thomas Behrenbeck, M.D.
Dr. Thomas Behrenbeck is a native of Germany, where he received his medical education at the Westfalian Wilhelm University in Munster and became board certified in internal medicine and cardiology.
He also received a Ph.D. in biophysics and physiology at the University of Minnesota. Dr. Behrenbeck joined the Mayo Clinic staff in 1990 and is currently an associate professor at Mayo Medical School and an academic faculty member at the Westfalian Wilhelm University. He is chair of the Cardiovascular Medicine and Surgery NetWork of the American College of Chest Physicians.
Dr. Behrenbeck is a noninvasive cardiologist, specializing in cardiovascular (CV) imaging modalities (echocardiography, nuclear cardiology, and CT), coronary artery disease and prevention of coronary artery disease. His research interests are the application of imaging technology to early recognition and treatment of atherosclerosis. He is passionate about patients' involvement in their health issues.
"The Internet and patient education present ideal synergies in the ever-growing field of knowledge in cardiology," he said.
More answers
- Coenzyme Q10: Can it prevent statin side effects?
- Arcus senilis: A sign of high cholesterol?
- Cholesterol test kits: Are they accurate?
- High cholesterol treatment: Does cinnamon lower cholesterol?
- LDL apheresis: Can it lower LDL cholesterol?
- Rhabdomyolysis from statins: What's the risk?
- Cholesterol level: Can it be too low?
- Kefir: Can it lower my cholesterol?
- Noni juice: Can it reduce cholesterol?
- VLDL cholesterol: What is it?
- Soy: Does it reduce cholesterol?
- Cholesterol ratio: Is it important?
- Zocor: Do I have to take it at night?
- Eggs: Are they good or bad for my cholesterol?
- Pomegranate juice: Can it lower cholesterol?
- Lipitor and Zocor: Are they equally effective?
- Niacin overdose: What are the symptoms?
- see all
Mayo Clinic Health Manager
Get free personalized health guidance for you and your family.
Get Started
Mayo Clinic Housecall
Stay up to date on the latest health information.
What you get
- Free weekly e-newsletter
- Mayo Clinic expertise
- Recipes, tools and other helpful information
- We do not share your e-mail address
Question
Statins: Do they cause ALS?
Is there any link between statin use and amyotrophic lateral sclerosis (ALS)? I know statins can cause muscle damage in some people. Could statin use trigger ALS in people predisposed to the disease?
Answer
from Thomas Behrenbeck, M.D.
There have been reports of individuals who have developed amyotrophic lateral sclerosis (ALS) while taking statins. However, at this time, there is no good evidence that statins cause or trigger ALS, also known as Lou Gehrig's disease.
ALS is a serious degenerative neurological disorder that is due to disease and death of the nerve cells in the brain and spinal cord that control voluntary muscles. ALS may begin with muscle twitching, weakness in an arm or leg, or changes in speech (dysarthria). Eventually, it affects the ability to control the muscles needed to move, speak, eat and breathe.
Statins are medications prescribed for the treatment of high cholesterol. These medications can sometimes cause muscle pain (myalgia), muscle weakness and rarely severe muscle damage (rhabdomyolysis). But these occur as a result of direct muscle damage, not damage to nerve cells.
Next question
